Safety of Maternal Immunization Against Pertussis: A Systematic Review

Infectious Diseases and Therapy

Charlotte Switzer¹  Denis Macina²  Caroline D’Heilly² 

[1] Sanofi Pasteur, Pharmacoepidemiology;Sanofi Pasteur, Vaccines Epidemiology and Modeling;

关键词: Maternal immunization;    Pertussis;    Pregnancy;    Vaccine;    Whooping cough;   

DOI  :  10.1007/s40121-019-00265-6

来源: DOAJ

【 摘 要 】

Abstract The WHO recommends vaccination of all children against pertussis. However, newborn infants remain vulnerable to infection. Pertussis vaccination during pregnancy has been introduced in several countries to protect newborns via transplacental transfer of maternal pertussis antibodies to the infant. We reviewed the impact of maternal pertussis vaccination on the health of pregnant women, the developing fetus, and health of the newborn. We searched PubMed/MEDLINE, EMBASE, Scopus (Elsevier), Cochrane Database of Systematic Reviews, ProQuest, and Science Direct to identify studies that assessed the safety of maternal pertussis vaccination. Twenty-seven English language publications published between January 1995 and December 2018 were included in this review. Pregnant women receiving pertussis vaccines did not have increased rates of systemic or local reactions. There were no safety concerns with repeat vaccination with other tetanus-containing vaccines or their concomitant administration with influenza vaccines. Maternal pertussis vaccination did not adversely affect pregnancy, birth or neonatal outcomes. This review confirms the safety of maternal pertussis vaccination during pregnancy. Funding Sanofi Pasteur. Plain Language Summary Plain language summary available for this article.

【 授权许可】

Unknown